Ampliar

Pages 71 (January 2012)

Summary of the Clinical Studies Reported in the Annual Scientific Sessions of the American Heart Association (Orlando, United States, November 12-16, 2011)

Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales de la American Heart Association (Orlando, Estados Unidos, 12-16 de noviembre de 2011)

Pablo Avanzasa Antoni Bayes-GenisaLeopoldo Pérez de IslaaJuan SanchisaMagda Herasb

https://doi.org/10.1016/j.rec.2011.11.001

View PDF

Lea este artículo en español

Options

Other articles of interest

Statistics

2804 Total PDF

5261 Total HTML

Year/month	Html	Pdf	Total
2024 October	1	0	1
2024 September	41	12	53
2024 August	52	22	74
2024 July	32	11	43
2024 June	36	19	55
2024 May	38	11	49
2024 April	40	24	64
2024 March	37	19	56
2024 February	29	34	63
2024 January	19	16	35
2023 December	31	22	53
2023 November	22	31	53
2023 October	33	34	67
2023 September	19	22	41
2023 August	6	15	21
2023 July	11	22	33
2023 June	17	12	29
2023 May	7	8	15
2022 November	2	0	2
2022 October	22	27	49
2022 September	21	25	46
2022 August	26	43	69
2022 July	15	24	39
2022 June	26	27	53
2022 May	25	29	54
2022 April	23	38	61
2022 March	30	42	72
2022 February	16	18	34
2022 January	18	22	40
2021 December	19	30	49
2021 November	22	35	57
2021 October	20	37	57
2021 September	16	23	39
2021 August	18	31	49
2021 July	15	19	34
2021 June	19	15	34
2021 May	20	13	33
2021 April	25	21	46
2021 March	38	24	62
2021 February	19	18	37
2021 January	17	13	30
2020 December	19	15	34
2020 November	11	9	20
2020 October	17	13	30
2020 September	15	2	17
2020 August	19	8	27
2020 July	13	10	23
2020 June	15	15	30
2020 May	12	26	38
2020 April	11	13	24
2020 March	11	17	28
2020 February	15	5	20
2020 January	17	15	32
2019 December	22	15	37
2019 November	9	11	20
2019 October	13	10	23
2019 September	11	18	29
2019 August	20	14	34
2019 July	26	25	51
2019 June	25	23	48
2019 May	21	9	30
2019 April	30	16	46
2019 March	36	13	49
2019 February	39	17	56
2019 January	47	12	59
2018 December	60	17	77
2018 November	41	8	49
2018 October	48	14	62
2018 September	12	7	19
2018 August	29	10	39
2018 July	53	13	66
2018 June	53	10	63
2018 May	38	9	47
2018 April	34	4	38
2018 March	34	5	39
2018 February	35	9	44
2018 January	37	4	41
2017 December	26	3	29
2017 November	22	7	29
2017 October	26	2	28
2017 September	16	11	27
2017 August	20	14	34
2017 July	18	10	28
2017 June	36	9	45
2017 May	20	12	32
2017 April	16	5	21
2017 March	17	21	38
2017 February	29	3	32
2017 January	70	5	75
2016 December	31	6	37
2016 November	26	4	30
2016 October	74	4	78
2016 September	141	7	148
2016 August	28	4	32
2016 July	61	14	75
2016 June	46	18	64
2016 May	34	28	62
2016 April	35	31	66
2016 March	39	17	56
2016 February	76	27	103
2016 January	44	13	57
2015 December	41	10	51
2015 November	32	21	53
2015 October	63	33	96
2015 September	81	51	132
2015 August	74	54	128
2015 July	72	37	109
2015 June	60	31	91
2015 May	85	39	124
2015 April	65	25	90
2015 March	58	13	71
2015 February	63	17	80
2015 January	43	6	49
2014 December	52	7	59
2014 November	43	7	50
2014 October	42	5	47
2014 September	45	8	53
2014 August	55	13	68
2014 July	47	10	57
2014 June	61	7	68
2014 May	77	16	93
2014 April	59	9	68
2014 March	86	15	101
2014 February	63	5	68
2014 January	76	13	89
2013 December	73	14	87
2013 November	75	14	89
2013 October	82	14	96
2013 September	71	38	109
2013 August	85	108	193
2013 July	60	102	162
2013 June	52	88	140
2013 May	57	85	142
2013 April	46	78	124
2013 March	54	50	104
2013 February	31	37	68
2013 January	13	40	53
2012 December	17	40	57
2012 November	15	12	27
2012 October	6	8	14
2012 September	239	0	239

Este artículo solo puede leerse en pdf

Bibliography

[1]

Bermejo J, Segovia J, Alfonso F..

Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales de la American Heart Association (New Orleans, Estados Unidos, 8-12 de noviembre de 2008)..

Rev Esp Cardiol. , (2009), 62 pp. 178-187

[2]

Segovia J, Bermejo J, Alfonso F..

Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales del American College of Cardiology (Orlando, Estados Unidos, 28-31 de marzo de 2009)..

Rev Esp Cardiol. , (2009), 62 pp. 660-669

Medline

[3]

Heras M, Bermejo J, Segovia J, Alfonso F..

Resumen de los ensayos clínicos presentados en las sesiones científicas del Congreso de la Sociedad Europea de Cardiología (Barcelona, España, 29 de agosto-2 de septiembre de 2009)..

Rev Esp Cardiol. , (2009), 62 pp. 1149-1160

Medline

[4]

Pérez de Isla L, Bayes-Genis A, Sanchis J, Heras M..

Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales de la American Heart Association (Orlando, Estados Unidos, 14-18 de noviembre de 2009)..

Rev Esp Cardiol. , (2010), 63 pp. 190-199

Medline

[5]

Pérez de Isla L, Bayes-Genis A, Sanchis J, Heras M..

Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales del American College of Cardiology (Atlanta, Estados Unidos, 14-16 de marzo de 2010)..

Rev Esp Cardiol. , (2010), 63 pp. 695-707

Medline

[6]

Bayes-Genis A, Avanzas P, Pérez de Isla L, Sanchis J, Heras M..

Resumen de estudios clínicos presentados en el Congreso de 2010 de la European Society of Cardiology (28 de agosto-1 de septiembre de 2010, Estocolmo, Suecia)..

Rev Esp Cardiol. , (2010), 63 pp. 1292-1303

Medline

[7]

Avanzas P, Pérez de Isla L, Bayes-Genis A, Sanchis J, Heras M..

Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales de la American Heart Association (Chicago, Estados Unidos, 13-17 de noviembre de 2010)..

Rev Esp Cardiol. , (2011), 64

http://dx.doi.org/10.1016/j.recesp.2011.08.002 | Medline

[8]

Avanzas P, Pérez de Isla L, Bayes-Genis A, Sanchis J, Heras M..

Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales del American College of Cardiology (Nueva Orleans, Luisiana, Estados Unidos, 2-5 de abril de 2011)..

Rev Esp Cardiol. , (2011), 64

http://dx.doi.org/10.1016/j.recesp.2011.08.002 | Medline

[9]

Avanzas P, Bayes-Genis A, Pérez de Isla L, Sanchis J, Heras M..

Resumen de estudios clínicos presentados en el Congreso de 2011 de la European Society of Cardiology (27-30 de agosto de 2011, París, Francia)..

Rev Esp Cardiol. , (2011), 64

http://dx.doi.org/10.1016/j.recesp.2011.08.002 | Medline

[10]

Kastrati A, Neumann FJ, Schulz S, Massberg S, Byrne RA, Ferenc M, et al. Abciximab and heparin versus bivalirudin for non–ST-elevation myocardial infarction [cited 16 Nov 2011]. N Engl J Med. 2011 Nov 16. Available at: http://www.nejm.org/doi/full/10.1056/NEJMoa1109596?query=featured_home..

[11]

The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) Trial [citado 15 Nov 2011]. Disponible en: http://www.abstractsonline.com/plan/ViewAbstract.aspx?mID=2654&sKey=46715a37-a068-4cc0-b37a-51568b3bd230&ckey=6c56085f-30f6-4ca3-9841-242b175fa8dd&mKey=%7bFA42FAFA-40B7-42EE-A779-1A1AF9DA6ECE%7d..

[12]

Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, et al. Rivaroxaban in patients with a recent acute coronary syndrome [citado 16 Nov 2011]. N Engl J Med. 2011 Nov 13. Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMoa1112277?query=featured_home..

[13]

Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention: AIDA STEMI Trial [citado 15 Nov 2011]. Disponible en: http://www.abstractsonline.com/plan/ViewAbstract.aspx?mID=2654&sKey=46715a37-a068-4cc0-b37a-51568b3bd230&ckey=52475fa4-5d7e-4b96-864e-5203d0bf1590&mKey=%7bFA42FAFA-40B7-42EE-A779-1A1AF9DA6ECE%7d..

[14]

Testing an evidence-based, individualized informed consent form to improve patients’ experiences with PCI [citado 15 Nov 2011]. Disponible en: http://www.abstractsonline.com/plan/ViewAbstract.aspx?mID=2654&sKey=f0ac2a57-c80b-45c6-b3a0-ca44f81a6733&ckey=d454362f-c3d5-464a-ad5c-3cd41de70840&mKey=%7bFA42FAFA-40B7-42EE-A779-1A1AF9DA6ECE%7d..

[15]

Outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery: a randomized study [citado 15 Nov 2011]. Disponible en: http://www.abstractsonline.com/plan/ViewAbstract.aspx?mID=2654&sKey=f0ac2a57-c80b-45c6-b3a0-ca44f81a6733&ckey=49931b1d-7156-417a-94a0-d8951a96a06d&mKey={FA42FAFA-40B7-42EE-A779-1A1AF9DA6ECE}..

[16]

Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of Celivarone 50, 100 or 300 mg OD with Amiodarone as Calibrator for the Prevention of ICD Interventions or Death (ALPHEE) [citado 15 Nov 2011]. Disponible en: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_433343.pdf..

[17]

Atrial fibrillation catheter ablation versus surgical ablation treatment: a multicenter randomized clinical trial [citado 15 Nov 2011]. Disponible en: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_433344.pdf..

[18]

A randomized multicenter comparison of radiofrequency ablation and antiarrhythmic drug therapy as first-line treatment in 294 patients with paroxysmal atrial fibrillation [citado 15 Nov 2011]. Disponible en: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_433345.pdf..

[19]

Connolly SJ, Camm AJ, Halperin JL, Joyner C, Alings M, Amerena J, et al. Dronedarone in high-risk permanent atrial fibrillation [cited 16 Nov 2011]. N Engl J Med. 2011 Nov 14. Available at: http://www.nejm.org/doi/full/10.1056/NEJMoa1109867..

[20]

Imazio M, Brucato A, Ferrazzi P, Rovere ME, Gandino A, Cemin R, et al. Colchicine reduces postoperative atrial fibrillation. Results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) Atrial Fibrillation Substudy [cited 16 Nov 2011]. Circulation. 2011 Nov 16. Available at: http://circ.ahajournals.org/content/124/21/2290.abstract..

[21]

The AIM-HIGH Investigators. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy [cited 16 Nov 2011]. N Engl J Med. 2011 Nov 15. Available at: http://www.nejm.org/doi/full/10.1056/NEJMoa1107579?query=featured_home..

[22]

Appel LJ, Clark JM, Yeh HC, Wang NY, Coughlin JW, Daumit G, et al. Comparative Effectiveness of weight-loss interventions in clinical practice [cited 16 Nov 2011]. N Engl J Med. 2011 Nov 15. Available at: http://www.nejm.org/doi/full/10.1056/NEJMoa1108660..

[23]

Nicholls SJ, Ballantyne CM, Barter PJ, Chapman MJ, Erbel RM, Libby P, et al. Effect of two intensive statin regimens on progression of coronary disease [cited 16 Nov 2011]. N Engl J Med. 2011 Nov 15. Available at: http://www.nejm.org/doi/full/10.1056/NEJMoa1110874?query=featured_home&..

[24]

Nicholls SJ, Brewer HB, Kastelein JJP, Krueger KA, Wang, et al..

Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol [cited 16 Nov 2011]..

JAMA. , (2011), 306 pp. 2099-2109

http://dx.doi.org/10.1001/jama.2011.1649 | Medline

[25]

Choudhry NK, Avorn J, Glynn RJ, Antman EM, Schneeweiss S, Michele Toscano M, et al. Full coverage for preventive medications after myocardial infarction [cited 16 Nov 2011]. N Engl J Med. 2011 Nov 14. Available at: http://www.nejm.org/doi/full/10.1056/NEJMsa1107913?query=featured_home..

[26]

Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction [cited 15 Nov 2011]. Eur Heart J. 2011 Nov 14. Available at: http://eurheartj.oxfordjournals.org/content/early/2011/11/13/eurheartj.ehr433.long..

[27]

Goldhaber SZ, Leizorovicz A, Kakkar AK, Haas SK, Merli G, Knabb RM, et al. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients [cited 15 Nov 2011]. N Engl J Med. 2011 Nov 13. Available at: http://www.nejm.org/doi/full/10.1056/NEJMoa1110899..

[28]

Early surgery versus conventional treatment for infective endocarditis [cited 16 Nov 2011]. Available at: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_433351.pdf..

[29]

Murphy TP, Cutlip DE, Regensteiner JG, Mohler ER, Cohen DJ, Reynolds MR, et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease. Six-month outcomes from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) Study [cited 16 Nov 2011]. Circulation. 2011 Nov 16. Available at: http://circ.ahajournals.org/content/early/2011/11/15/CIRCULATIONAHA.111.075770.abstract..

[30]

Mega JL, Hochholzer W, Frelinger AL, Kluk MJ, Angiolillo DJ, Kereiakes DJ, et al. Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease [cited 16 Nov 2011]. JAMA. 2011 Nov 16. Available at: http://jama.ama-assn.org/content/early/2011/11/09/jama.2011.1703.long..

https://doi.org/10.1016/j.rec.2011.11.001

View PDF

Lea este artículo en español